Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GAVI
Pharma
Novavax paying up to $400M to evade Gavi COVID shot arbitration
After a turbulent 2023 in which Novavax’s very existence was at stake, the beleaguered vaccine maker has new reason to be optimistic about the future.
Fraiser Kansteiner
Feb 22, 2024 6:00am
Will Novavax survive 2023? Company raises doubts about future
Mar 1, 2023 8:00am
Moderna scraps vax supply deal with COVAX for new 2023 agreement
Oct 17, 2022 10:10am
UNICEF is snapping up 18M doses of GSK's malaria shot Mosquirix
Aug 17, 2022 8:54am
GSK's rotavirus shot runs short due to manufacturing issues
Aug 11, 2022 4:00pm
Merck is revving up HPV vaccine producting in Virginia
Apr 4, 2022 9:45am